Boehringer Ingelheim GmbH

Type: Company

Name: Boehringer Ingelheim GmbH

Nationality: Germany

Web Address: http://www.boehringer-ingelheim.se

Fact Sheet: Fact Sheet for Boehringer Ingelheim GmbH

First reported 3 hours ago - Updated 3 hours ago - 1 reports

Featured: Open Source Prosthetic Hand Can Be 3D Printed For $150

For patients who suffer traumatic injury resulting in the loss of a limb, or for children born with conditions such as Amniotic band syndrome (which often results in children being born without one or more fingers), a new prosthetic limb has the potential ... [Published PSFK - 3 hours ago]

Entities: 3D Printing, Boehringer Ingelheim GmbH, John Pugh, Open Source

First reported May 22 2013 - Updated 12 hours ago - 6 reports

FDA Food & Drug Administration

Boehringer in bother with FDA over manufacturing

Boehringer Ingelheim says it will act promptly to resolve a series of manufacturing complaints highlighted by regulators in the USA concerning violations at its German headquarters.The US Food and Drug Administration has issued a warning letter concerning ... [Published Pharma Times - 12 hours ago]

Entities: FDA Food & Drug Administration, Manufacturing, Warning Letter, Boehringer Ingelheim GmbH

First reported 23 hours ago - Updated 23 hours ago - 1 reports

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

This article is a follow-up to an article in our March 2012 update concerning the decision of the Swedish Medical Products Agency (the "MPA"), prohibiting Boehringer Ingelheim AB ("Boehringer") in September 2011 from advertising the prescription-based ... [Published Bird & Bird - 23 hours ago]

Entities: Pradaxa, Freedom of Speech, David Nilsson, Boehringer Ingelheim GmbH

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Pfizer Inc

Business briefs: Pfizer, Novartis, Boehringer Ingelheim, Elsevier

Pfizer is looking to set Zoetis free: the drug maker is looking to offload its stake in its animal health business, Zoetis, which became a standalone company in February Pfizer is offering shareholders the chance to swap PFE shares for ZTS ones in a stock-free ... [Published Medical Marketing And Media - May 22 2013]

Entities: Boehringer Ingelheim GmbH, Elsevier BV, Pfizer Inc, Novartis AG

First reported May 21 2013 - Updated May 22 2013 - 2 reports

Boehringer Ingelheim GmbH

MAXIMUM STRENGTH ZANTAC (Ranitidine) Tablet, Coated [Boehringer Ingelheim Promeco S.A. De C.V.]

Updated Date: May 22, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 22 2013]

Entities: Ranitidine, Zantac, Boehringer Ingelheim GmbH

First reported May 22 2013 - Updated May 22 2013 - 2 reports

Phase III Success for Boehringer Ingelheim Asthma Drug

Boehringer Ingelheim said today its once-daily asthma drug tiotropium, delivered via Respimat® Soft Mist™ Inhaler, produced favorable Phase III results by increasing the time to first severe exacerbation, and time to first episode of asthma worsening ... [Published Genetic Engineering News - May 22 2013]

Entities: Boehringer Ingelheim GmbH, Phase III, Patient

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Foundation Supports Life Sciences Evolvement at JGU

The Boehringer Ingelheim Foundation is providing support for top level research specifically associated with the field of life sciences at Johannes Gutenberg University Mainz (JGU), with a donation of EUR 50 million over the next ten years. The funding ... [Published Labmate Online - May 22 2013]

Entities: Life Science, Boehringer Ingelheim GmbH, Johannes Gutenberg, Biology

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Grant gives cityâs animal shelter a real shot in arm

The Humane Society of Harrison County was a recipient of a grant for vaccinations from the Petfinder Foundation, Boehringer Ingelheim and The Animal Rescue Site.The vaccinations were valued at more than $820 as part of the “A Shot at Life” initiative, ... [Published Marshall News Messenger - May 22 2013]

Entities: Vaccine, Boehringer Ingelheim GmbH, infections, Immunity

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Spain - Drug company awards to their own bloody salesmen (researchers in their pockets)

A project on porcine circovirus by Dr Marina Sibila and Dr Segalés was awarded at the 6th edition of the European PCV2 Research Award sponsored by Boehringer Ingelheim.Since 2007, Boehringer Ingelheim Animal Health has funded independent European research ... [Published Meat Trade News Daily - May 22 2013]

Entities: Boehringer Ingelheim GmbH, Spain, Independent Review, Infection, Animal Health

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Zealand to present at upcoming global healthcare investor conferences in the US

Copenhagen, 2013-05-21 15:00 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) ("Zealand"), Deutsche Bank 38th Annual Healthcare Conference, Boston (29-31 May 2013)Jefferies Global Healthcare Conference, NYC (3-6 June 2013)Presentation ... [Published Noodls - May 21 2013]

Entities: Health Care, Jefferies Global Healthcare Conference, David H Solomon, Hanne Leth Hillman, Zealand Pharma A/S

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Phase III results for afatinib and ninedanib

Boehringer Ingelheim has announced the upcoming presentation of data from 14 abstracts involving three of the company's investigational oncology compounds – afatinib, nintedanib and volasertib.Results, to be presented at the 49th Annual Meeting of the ... [Published Hospital Pharmacy Europe - May 21 2013]

Entities: non-small cell lung cancer, Phase III, Chemotherapy

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Boehringer's Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directorsBoehringer Ingelheim's Professor Wolfram Carius (pictured right) is to step down after 26 years with the German pharma company.He will leave Boehringer on June 30 as managing director ... [Published PMLive - May 21 2013]

Entities: Tungsten, Boehringer Ingelheim GmbH, Andreas Barner, Biopharmaceuticals

Quotes

"We will invest all our energy to remedy the situation in order to meet all FDA requests, building on the experience gained from all 22 inspections successfully passed at the Ingelheim site in the last five years by different authorities around the world, other than the latest FDA inspection in November."

Boehringer responds to FDA warning letter [Published Pharmaceutical Technology - 1 hour ago]

Gerhard Koeller, head of corporate division quality at Boehringer Ingelheim, responded by saying the firm takes this matter very seriously "and is fully committed to working with the FDA on a comprehensive action plan" that addresses the agency's concerns...

Boehringer in bother with FDA over manufacturing [Published Pharma Times - 12 hours ago]

...Richard Russell, Ph D , FRCP, consultant chest physician at the U K ’s Wexham Park Hospital, and a U K -based investigator in PrimoTinA-asthma. "There remains a significant number of asthma patients who continue to be symptomatic despite available therapeutic options. The results suggest tiotropium may be an efficacious treatment option for patients."

Phase III Success for Boehringer Ingelheim Asthma Drug [Published Genetic Engineering News - May 22 2013]

"Boehringer Ingelheim is taking this issue very seriously and is fully committed to working with the FDA on a comprehensive action plan that addresses the FDA’s concerns, ensuring that it implements corrective and preventive actions to optimise its quality systems. We are committed to compliance with current Good Manufacturing Practices requirements. We will invest all our energy to remedy the situation in order to meet all FDA requests, building on the experience gained from all 22 inspections successfully passed at the Ingelheim site in the last 5 years by different authorities around the world, other than the latest FDA inspection in November" said Dr Gerhard Koeller, Head of Corporate Division Quality at Boehringer Ingelheim

Boehringer Ingelheim responds to FDA warning letter [Published Boehringer Ingelheim - May 22 2013]

More Content

sort by: Date \| Relevance
Boehringer responds to FDA warning letter [Published Pharmaceutical Technology - 1 hour ago]
Ten IT-enabled business trends for the decade a... [Published McKinsey & Company - 2 hours ago]
Featured: Open Source Prosthetic Hand Can Be 3D... [Published PSFK - 3 hours ago]
The Coming Diabetes Wars [Published Motley Fool - 5 hours ago]
Porter Novelli Assigned Comms Duties For Potent... [Published Holmes Report - 9 hours ago]
Boehringer in bother with FDA over manufacturing [Published Pharma Times - 12 hours ago]
Court confirms that a press release to journali... [Published Bird & Bird - 23 hours ago]
Business briefs: Pfizer, Novartis, Boehringer I... [Published Medical Marketing And Media - May 22 2013]
New Oral Anticoagulants Markets [Published Zecco - May 22 2013]
MAXIMUM STRENGTH ZANTAC (Ranitidine) Tablet, Co... [Published DailyMed Drug Label Updates for the last seven ... - May 22 2013]
Phase III Success for Boehringer Ingelheim Asth... [Published Genetic Engineering News - May 22 2013]
Top Pharmaceutical Leaders Gathering in East Br... [Published Prlog - May 22 2013]
Boehringer Ingelheim responds to FDA warning le... [Published Boehringer Ingelheim - May 22 2013]
Foundation Supports Life Sciences Evolvement at... [Published Labmate Online - May 22 2013]
FDA warns Boehringer-Ingelheim over cGMP failings [Published Manufacturing Chemist - May 22 2013]
A Boehringer Ingelheim Corporation Shake Up and... [Published BioSpace - May 22 2013]
FDA cGMP Complaints Draw Boehringer Ingelheim P... [Published Genetic Engineering News - May 22 2013]
Boehringer Ingelheim handed FDA warning letter [Published FiercePharma - May 22 2013]
Deadly Drug Trials: Western Firms Bribed East G... [Published Spiegel Online - May 22 2013]
The 2013 Pharm Exec Top 50 [Published Pharmaceutical Executive - May 22 2013]
Survey indicates improved effect on quality of ... [Published Pro Health Service Zone - May 22 2013]
Boehringer Ingelheim's tiotropium shows promisi... [Published News-Medical.Net - May 22 2013]
Aethlon Medical AEMD Note: An Update on the Cli... [Published Pharmacy Choice - May 22 2013]
Pradaxa Lawsuit Draws More Potential Plaintiffs [Published PRWeb - May 22 2013]
Francis Cauffman Appoints Michael Bonomo as Pri... [Published PR.com Press Releases - May 22 2013]
Grant gives cityâs animal shelter a real shot i... [Published Marshall News Messenger - May 22 2013]
Spain - Drug company awards to their own bloody... [Published Meat Trade News Daily - May 22 2013]
Sponsors Leery of Joint Inspections [Published Applied Clinical Trials - May 21 2013]
5-Day Steroid Tx Works in COPD (CME/CE) [Published MedPage Today - May 21 2013]
ZANTAC 75 (Ranitidine) Tablet, Coated [Boehring... [Published DailyMed Drug Label Updates for the last seven ... - May 21 2013]